FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061919145> ?p ?o ?g. }

• W2061919145 endingPage "235" @default.
• W2061919145 startingPage "225" @default.
• W2061919145 abstract "Annals of the New York Academy of SciencesVolume 841, Issue 1 p. 225-235 Mechanisms and Genetics of Autoimmunitya ARGYRIOS N. THEOFILOPOULOS, ARGYRIOS N. THEOFILOPOULOS Department of Immunology; The Scripps Research Institute; La Jolla, California 92037Search for more papers by this authorDWIGHT H. KONO, DWIGHT H. KONO Department of Immunology; The Scripps Research Institute; La Jolla, California 92037Search for more papers by this author ARGYRIOS N. THEOFILOPOULOS, ARGYRIOS N. THEOFILOPOULOS Department of Immunology; The Scripps Research Institute; La Jolla, California 92037Search for more papers by this authorDWIGHT H. KONO, DWIGHT H. KONO Department of Immunology; The Scripps Research Institute; La Jolla, California 92037Search for more papers by this author First published: 07 February 2006 https://doi.org/10.1111/j.1749-6632.1998.tb10932.xCitations: 16 a This is Publication No. 11338IMM from the Department of Immunology, The Scripps Research Institute. The work reported herein was supported in part by NIH Grant Nos. AR39555, AR31203, and AR42242. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Theofilopoulos, A. N., 1995. The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition. Immunol. Today 16: 90–98. 2 Ando, K., L. G. Guidotti, A. Cerny, T. Ishikawa & F. V. Chisari. 1994. CTL access to tissue antigen is restricted in vivo. J. Immunol. 153: 482–488. 3 Herold, K. C., A. G. Montag, & F. Buckingham. 1992. Induction of tolerance to autoimmune diabetes with islet antigens. J. Exp. Med. 176: 1107–1114. 4 Posselt, A. M., C. F. Barker, A. L. Friedman & A. Naji. 1992. Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth. Science 256: 1321–1324. 5 Gerling, I. C., D. V. Serreze, S. W. Christianson & E. H. Leiter. 1992. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice. Diabetes 41: 1672–1676. 6 Kaufman, D. L., M. Clare-Salzler, J. Tian, T. Forsthuber, G. S. Ting, P. Robinson, M. A. Atkinson, E. E. Sercarz, A. J. Tobin & P. V. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69–72. 7 Tisch, R., X. D. Yang, S. M. Singer, R. S. Liblau, L. Fugger & H. O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72–75. 8 Khoury, S. J., M. H. Sayegh, W. W. Hancockm, L. Gallon, C. B. Carpenter & H. L. Weiner. 1993. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide. J. Exp. Med. 178: 296–559. 9 Duncan, S. R., R. L. Rubin, R. W. Burlingame, S. B. Sinclair, K. W. Pekny & A. N. Theofilopoulos. 1996. Intrathymic injection of polynucleosomes delays autoantibody production in BXSB mice. Clin. Immunol. Immunopathol. 79: 171–181. 10 Sercarz, E. E., P. V. Lehmann, A. Ametani, G. Benichou, A. Miller & K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11: 729–766. 11 Moudgil, K. D., & E. E. Sercarz. 1994. The T cell repertoire against cryptic self determinants and its involvement in autoimmunity and cancer. Clin. Immunol. Immunopathol. 73: 283–289. 12 Milich, D. R., F. Schodel, D. L. Peterson, J. E. Jones & J. L. Hughes. 1995. Characterization of self-reactive T cells that evade tolerance in hepatitis B antigen transgenic mice. Eur. J. Immunol. 25: 1663–1672. 13 Lanzavecchia, A. 1997. Understanding the mechanisms of sustained signaling and T cell activation. J. Exp. Med. 185: 1717–1719. 14 Ohashi, P. S., S. Oehen, K. Buerki, H. Pircher, C. T. Ohashi, C. Odermatt, B. Malissen, R. M. Zinkernagel & H. Hengartner. 1991. Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65: 305–317. 15 Oldstone, M. B., M. Nerenberg, P. Southern, J. Price & H. Lewicki. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65: 319–331. 16 Oldstone, M. B., 1996. Principles of viral pathogenesis. Cell 87: 799–801. 17 Lin, R. H., M. J. Mamula, J. A. Hardin & C, A. Janeway, Jr. 1991. Induction of autoreactive B cells allows priming of autoreactive T cells. J. Exp. Med. 173: 1433–1439. 18 Mamula, M. J., R. H. Lin, C. A. Janeway, Jr. & J. A. Hardin. 1992. Breaking T cell tolerance with foreign and self co-immunogens: a study of autoimmune B and T cell epitopes of cytochrome c. J. Immunol. 149: 789–795. 19 Wucherpfennig, K. W., & J. L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80: 695–705. 20 Gautam, A.M., C. I. Pearson, D. E. Smilek. L. Steinman & H. O. Mcdevitt. 1992. A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis. J. Exp. Med. 176: 605–609. 21 Evavold, B. D., J. Sloan-Lancaster, K. J. Wilson, J. B. Rothbard & P. M. Allen. 1995. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 2: 655–663. 22 Bhardwaj, V., V. Kumar, H. M. Geysen & E. E. Sercarz. 1993. Degenerate recognition of a dissimilar antegenic peptide by myelin basic protein reactive T cells: implications for thymic education and autoimmunity. J. Immunol. 151: 5000–5010. 23 Hemmer, B., B. T. Fleckenstein, M. Vergelli, G. Jung, H. Mcfarland, R. Martin & K. H. Wiesmuller. 1997. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J. Exp. Med. 185: 1651–1659. 24 Lehmann, P. V., E. E. Sercarz, T. Forsthuber, C. M. Dayan & G. Gammon. 1993. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today 14: 203–408. 25 Topper, F., T. Gordon & J. Mccluskey. 1995. Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc. Natl. Acad. Sci. U.S.A. 92: 875–879. 26 Garza, K. M., N. D. Griggs & K. S. Tung. 1997. Neonatal injection of an ovarian peptide induces autoimmune ovarian disease in female mice: requirement of endogenous neonatal ovaries. Immunity 6: 89–96. 27 Casiano, C. A., & E. M. Tan. 1996. Recent developments in the understanding of antinuclear autoantibodies. Int. Arch. Allergy Immunol. 111: 308–313. 28 Quaratino, S., C. J. Thorpe, P. J. Travers & M. Londei. 1995. Similar antegenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry. Proc. Natl. Acad. Sci. U.S.A. 92: 10398–10402. 29 Nagata, S. 1997. Apoptosis by death factor. Cell 88: 355–365. 30 Bettinardi, A., D. Brugnoni, E. Quiros-Roldan, A. Malagoli, S. Lagrutta, A. Correra & L. D. Notarangelo. 1997. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. Blood 89: 902–909. 31 Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. Middleton, A. Y. Lin, W. Strober, M. J. Lenardo & J. M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935–946. 32 Rieux-Laucat; F., F. Le Deist, C. Hivroz, I. A. G. Roberts, K. M. Debatin, A. Fischer & J. P. De Villartay. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347–1349. 33 Giordano, C., G. Stassi, R. De Maria, M. Todaro P. Richiusa, G. Papoff, G. Ruberti, M. Bagnasco, R. Testi & A. Galluzzo. 1997. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroidiris. Science 275: 960–963. 34 Chervonsky, A. V., Y. Wang, F. S. Wong, I. Visintin, R. A. Flavell, C. A. Janeway, Jr & L. A. Matis. 1997. The role of Fas in autoimmune diabetes. Cell 89: 17–24. 35 Griffin, T. S., T. Brunner, S. M. Fletcher, D. R. Green & T. A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189–1192. 36 Bellgrau, D., D. Gold, H. Selawry, J. Moore, Z. Franzusoff & R. C. Duke. 1995. A role for CD95 ligand in preventing graft rejection. Nature 377: 630–632. 37 Streilein, J. W., 1995. Unraveling immune privilege. Science 270: 1158–1159. 38 Weissman, S. M., 1995. Genetic bases for common polygenic diseases. Proc. Natl. Acad. Sci. U.S.A. 92: 8543–8544. 39 Risch, N., & K. Merikangas. 1996. The future of genetic studies of complex human diseases. Science 273: 1516–1517. 40 Lander, E. S., & L. Kruglyak. 1995. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11: 241–247. 41 Shultz, L. D., P. A. Schweitzer, T. V. Rajan, T. YI, J. N. Ihle, R. J. Matthews, M.L. Thomas & D. R. Beier. 1993. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73: 1445–1454. 42 Tsui, H. W., K. A. Siminovitch, L. Desouza & F. W. L. Tsui. 1995. Motheaten and viable motheaten mice have mutations in the hematopoietic cell phosphatase gene. Nat. Genet. 4: 124–129. 43 Stallings, R. L., D.C. Torney, C. E. Hilderbrand, J. L. Longmire, L. L. Deaven, J. H. Jett, N. A. Doggett & R. K. Moyzis. 1990. Physical mapping of human chromosomes by repetitive sequence fingerprinting. Proc. Natl. Acad. Sci. U.S.A. 87: 6218–6222. 44 Kono, D. H., R. W. Burlingame, D. G. Owens, A. Kuramochi, R. S. Balderas, D. Balomenos & A. N. Theofilopoulos. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. U.S.A. 91: 10168–10172. 45 Vidal, S., D. H. Kono & A. N. Theofilopoulos. 1997. Loci predisposing to autoimmunity in MRL-Fas1pr and C57BL/6-Faslpr mice. J. Clin. Invest. In press. 46 Vyse, T. J., & J. A. Todd. 1996. Genetic analysis of autoimmune disease. Cell 85: 311–318. 47 Encinas, J. A., M. B. Lees, R. A. Sobel, C. Symonowicz, J. M. Greer, C. L. Shovlin, H. L. Weiner, C. E. Seidman, J. G. Seidman & V. K. Kuchroo. 1996. Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. J. Immunol. 157: 2186–2192. 48 Baker, D., O. A. Rosenwasser, J. K. O'Neill & J. L. Turk. 1995. Genetic analysis of experimental allergic encephalomyelitis in mice. J. Immunol. 155: 4046–051. 49 Sundvall, M., J. Jirholt, H. T. Yang, L. Jansson, A. Engstrom, U. Pettersson & R. Holmdahl. 1995. Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat. Genet. 10: 313–317. 50 Kuokkanen, S., M. Sundvall, J. D. Terwilleger, P. J. Tiernari, J. Wikstrom, R. Holmdahl, U. Pettersson & L. Peltonen. 1996. A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nat. Genet. 13: 477–480. 51 Ebers, G. C., K. Kukay, D. E. Bulman, A.D. Sadovnick, G. Rice, C. Anderson, H. Armstrong, K. Cousin, R. B. Bell, W. Hader, D. W. Paty, S. Hashimoto, J. Oger, P. Duqiette, S Warren, T. Gray, P. O'Connor, A. Nath, A. Auty, L. Metz, G. Francis, J. E. Paulseth, T. J. Murray, W. Pryse-Phillips, N. Risch et al. 1996. A full genome search in multiple sclerosis. Nat. Genet. 13: 472–476. 52 Haines, J. L., M. Ter-Minassian, A. Bazyk J. F. Gusella, D. J. Kim, H. Terwedow, M. A. Pericak-Vance, J. B. Rimmler, C. S. Haynes, A. D. Roses, A. Lee, B. Shaner, M. Menold, E. Seboun, R. P. Fitoussi, C. Gartioux, C. Reyes, F. Ribierre, G. Gyapay, J. Weissenbach, S. L. Hauser, D. E. Goodkin, R. Lincoln, K. Usiju, J. R. Oksenberg et al. 1996. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex: The Multiple Sclerosis Genetics Group. Nat. Genet. 13: 469–471. 53 Wardell, B. B., S. D. Michael, K. S. Tung, J. A. Todo, E. P. Blankenhorn, K. McEntee, J. D. Sudweeks, W. K. Hansen, N. D. Meeker, J. S. Griffith et al. 1995. Aod1, the immunoregulatory locus controlling abrogation of tolerance in neonatal thymectomy-induced autoimmune ovarian dysgenesis, maps to mouse chromosome 16. Proc. Natl. Acad. Sci. U.S.A. 92: 4758–4762. 54 Meeker, N. D., W. F. Hickey R. Korngol D, W. K. Hansen, J. D. Sudweeks, B. B. Wardell, J. S. Griffith & C. Teuscher. 1995. Multiple loci govern the bone marrow-derived immunoregulatory mechanism controlling dominant resistance to autoimmune orchitis. Proc. Natl. Acad. Sci. U.S.A. 92: 2988–5684. 55 Morel, L., U. H. Rudofsky, J. A. Longmate, J. Schiffenbauer & E. K. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1: 219–229. 56 Drake, C. G., S. K. Babcock, E. Palmer & B. L. Kotzin. 1994. Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB × NZW) FI mice. Proc. Natl. Acad. Sci. U.S.A. 91: 4062–4066. 57 Vyse, T. J., S. J. Rozzo, C. G. Drake, S. Izui & B. L. Kotzin. 1997. Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand black mice. J. Immunol. 158: 5566–5574. 58 Jiang, Y., S. Hirose, Y. Hamano, S. Kodera, H. Tsurui, M. Abe, K. Terashima, S. Ishikawa & T. Shirai. 1997. Mapping of a gene for the increased susceptibility of B1 cells to Mott cell formation in murine autoimmune disease. J. Immunol. 158: 992–997. 59 Morel, L., C. Mohan, Y. Yu, B. P. Croker, N. Tian, A. Deng & E. K. Wakeland. 1997. Functional dissection of systemic lupus erythematosus using congenic mouse strains. J. Immunol. 158: 6019–6028. 60 Mohan, C., L. Morel, P. Yang & E. K. Wakeland. 1997. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. J. Immunol. 159: 454–465. 61 Watson, M. L., J. K. Rao, G. S. Gilkeson. P. Ruiz, E. M. Eicher, D. S. Pisetsky, A. Mat-suzawa, J. M. Rochelle & M. F. Seldin. 1992. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 176: 1645–1656. 62 Tsao, B. P., R. M. Cantor, K. C. Kalunian, C. J. Chen, H. Badsha, R. Singh, D. J. Wallace, R. C. Kitridou, S. L. Chen, Y. W. Song, D. A. Isenberg, C. L. Yu, B.H. Hahn & J. I. Rotter. 1997. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J. Clin. Invest. 99: 725–731. 63 Djabiri, F, S. Caillat-Zucman, P. Gajdos, J. P. Jais, L. Gomez, I. Khalil, D. Charron, J. F. Bach & H. J. Garchon. 1997. Association of the AChRalpha-subunit gene (CHRNA), DQAl *0101, and the DR3 haplotype in myasthenia gravis: evidence for a three-gene disease model in a subgroup of patients. J. Autoimmun. 10: 407–413. 64 Christodoulou, K., M. Tsingis, F. Deymeer, P. Serdaroglu, C. Ozdemir, A. Al-Sherab, C. Bairactaris, I. Mavromatis, I. Mylonas, A. Evoli, K. Kyriallis & L. T. Middleton. 1997. Mapping of the familial myasthenia (congenital myasthenic syndrome type la) gene to chromosome 17p with evidence of genetic homogeneity. Hum. Mol. Genet. 6: 635–640. Citing Literature Volume841, Issue1MYASTHENIA GRAVIS AND RELATED DISEASES: DISORDERS OF THE NEUROMUSCULAR JUNCTIONMay 1998Pages 225-235 ReferencesRelatedInformation" @default.
• W2061919145 created "2016-06-24" @default.
• W2061919145 creator A5004663851 @default.
• W2061919145 creator A5038738015 @default.
• W2061919145 date "1998-05-01" @default.
• W2061919145 modified "2023-09-27" @default.
• W2061919145 title "Mechanisms and Genetics of Autoimmunitya" @default.
• W2061919145 cites W1514099677 @default.
• W2061919145 cites W1527959728 @default.
• W2061919145 cites W1534821225 @default.
• W2061919145 cites W1551211408 @default.
• W2061919145 cites W1564484262 @default.
• W2061919145 cites W1573565901 @default.
• W2061919145 cites W1581871973 @default.
• W2061919145 cites W1639677870 @default.
• W2061919145 cites W1771941672 @default.
• W2061919145 cites W1785576758 @default.
• W2061919145 cites W1964059727 @default.
• W2061919145 cites W1973951821 @default.
• W2061919145 cites W1976741643 @default.
• W2061919145 cites W1978018492 @default.
• W2061919145 cites W1981482475 @default.
• W2061919145 cites W1985498366 @default.
• W2061919145 cites W1993948601 @default.
• W2061919145 cites W1994892378 @default.
• W2061919145 cites W1995201985 @default.
• W2061919145 cites W1996319171 @default.
• W2061919145 cites W2002503549 @default.
• W2061919145 cites W2011658568 @default.
• W2061919145 cites W2013839395 @default.
• W2061919145 cites W2018027744 @default.
• W2061919145 cites W2019970750 @default.
• W2061919145 cites W2021951643 @default.
• W2061919145 cites W2023466758 @default.
• W2061919145 cites W2037804577 @default.
• W2061919145 cites W2038108432 @default.
• W2061919145 cites W2038861342 @default.
• W2061919145 cites W2042103448 @default.
• W2061919145 cites W2046749316 @default.
• W2061919145 cites W2049615365 @default.
• W2061919145 cites W2053963673 @default.
• W2061919145 cites W2057509968 @default.
• W2061919145 cites W2063058354 @default.
• W2061919145 cites W2070587287 @default.
• W2061919145 cites W2073317648 @default.
• W2061919145 cites W2074290635 @default.
• W2061919145 cites W2075036714 @default.
• W2061919145 cites W2076229621 @default.
• W2061919145 cites W2079997725 @default.
• W2061919145 cites W2085173450 @default.
• W2061919145 cites W2086336022 @default.
• W2061919145 cites W2086932628 @default.
• W2061919145 cites W2088477504 @default.
• W2061919145 cites W2089593597 @default.
• W2061919145 cites W2089947644 @default.
• W2061919145 cites W2090704440 @default.
• W2061919145 cites W2091951610 @default.
• W2061919145 cites W2107576399 @default.
• W2061919145 cites W2128857705 @default.
• W2061919145 cites W2129185631 @default.
• W2061919145 cites W2129210033 @default.
• W2061919145 cites W2130708019 @default.
• W2061919145 cites W2132594967 @default.
• W2061919145 cites W2139317542 @default.
• W2061919145 cites W2146056167 @default.
• W2061919145 cites W2154757961 @default.
• W2061919145 cites W2156448847 @default.
• W2061919145 cites W2163357710 @default.
• W2061919145 cites W2167325944 @default.
• W2061919145 cites W4236558915 @default.
• W2061919145 cites W4322385172 @default.
• W2061919145 doi "https://doi.org/10.1111/j.1749-6632.1998.tb10932.x" @default.
• W2061919145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9668244" @default.
• W2061919145 hasPublicationYear "1998" @default.
• W2061919145 type Work @default.
• W2061919145 sameAs 2061919145 @default.
• W2061919145 citedByCount "20" @default.
• W2061919145 countsByYear W20619191452012 @default.
• W2061919145 countsByYear W20619191452013 @default.
• W2061919145 crossrefType "journal-article" @default.
• W2061919145 hasAuthorship W2061919145A5004663851 @default.
• W2061919145 hasAuthorship W2061919145A5038738015 @default.
• W2061919145 hasConcept C54355233 @default.
• W2061919145 hasConcept C70721500 @default.
• W2061919145 hasConcept C86803240 @default.
• W2061919145 hasConceptScore W2061919145C54355233 @default.
• W2061919145 hasConceptScore W2061919145C70721500 @default.
• W2061919145 hasConceptScore W2061919145C86803240 @default.
• W2061919145 hasIssue "1" @default.
• W2061919145 hasLocation W20619191451 @default.
• W2061919145 hasLocation W20619191452 @default.
• W2061919145 hasOpenAccess W2061919145 @default.
• W2061919145 hasPrimaryLocation W20619191451 @default.
• W2061919145 hasRelatedWork W1920751942 @default.
• W2061919145 hasRelatedWork W1990804418 @default.
• W2061919145 hasRelatedWork W1991523530 @default.
• W2061919145 hasRelatedWork W2002128513 @default.
• W2061919145 hasRelatedWork W2020824267 @default.

• next